Interpretation and prediction of plasma levels of primaquine following transdermal delivery in Swiss mice

International Journal of Pharmaceutics

Volumn 155, Issue 1, 1997, Pages 99-107

  Mayorga, P ^a,b   Deharo, E ^c   Puisieux, F ^a   Couarraze, G ^a  

^a CNRS   (France)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Institut de recherche pour le developpement Bolivia   (Bolivia)

Author keywords

In vivo; Percutaneous absorption; Pharmacokinetic modelling; Primaquine; Transdermal drug delivery system

Indexed keywords

ANTIMALARIAL AGENT; PRIMAQUINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PHARMACOKINETICS; PREDICTION; PRIORITY JOURNAL; SKIN ABSORPTION; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030861996     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00151-8     Document Type: Article

References (18)

1. Auton, T.R., Ramsey, J.D., Woollen, B.H., 1993. Modelling dermal pharmacokinetics using in vitro data. Part I. Fluazifop-butyl in the rat. Hum. Exp. Toxicol. 12, 199-206.
2. Bhat, B.K., Seth, M., Bhaduri, A.P., 1984. Recents developments in 8-aminoquinoline antimalarials. Prog. Drug Res. 28, 197-231.
3. Bunge, A.L., Cleek, R.L., Wecchia, B.E., 1995. A new method for estimating dermal absorption from chemical exposure. 3. Compared with steady-state methods for prediction and data analysis. Pharm. Res. 12, 972-982.
4. Chandrasekaran, S.K., Bayne, W., Shaw, J.E., 1978. Pharmacokinetics of drug permeation through human skin. J. Pharm. Sci. 67, 1370-1374.
5. Clyde, D.F., 1981. Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bull. Who 59, 391-395.
6. Dean, R.A., Ochieng, W., Black, J., Queener, S.F., Bartlett, M.S., Dumaual, N.G., 1994. Simultaneous determination of primaquine and carboxyprimaquine in plasma using high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B 655, 89-96.
7. Diez-Sales, O., Sayas, E.P., Villodre, A.M., Dominguez, M.H., 1993. The prediction of percutaneous absorption: I. Influence of the dermis on in vitro permeation models. Int. J. Pharm. 100, 1-7.
8. Guy, R.H., Hadgraft, J., 1985. The prediction of plasma levels of drugs following transdermal application. J. Control. Release 1, 177-182.
9. Guy, R.H., Hadgraft, J., 1986. Interpretation and prediction of the kinetics of transdermal drug delivery: oestradiol, hyoscine and timolol. Int. J. Pharm. 32, 159-163.
10. Illel, B., Schaefer, H., Wepierre, J., Doucet, O., 1991. Follicles play an important role in percutaneous absorption. J. Pharm. Sci. 80, 424-427.
11. Mayorga, P., Puisieux, F., Couarraze, G., 1996. Formulation study of a transdermal delivery system of primaquine. Int. J. Pharm. 132, 71-79.
12. McDaid, D.M., Deasy, P.B., 1996. Formulation development of a transdermal drug delivery system for amlodipine base. Int. J. Pharm. 133, 71-83.
13. Nodiff, E.A., Chatterjee, S. and Musallam, H.A., Antimalarial activity of the 8-aminoquinolines. In Ellis, G.P. and West, G.P. (Eds), Progress in Medicine Chemistry, Vol. 28, Elsevier, Amsterdam, 1991, pp. 1-40.
14. Ogiso, T., Iwaki, M., Jing-Ping, Z., Tanino, T., Noguchi, A., 1994. Percutaneous absorption of betahistine through rat skin and pharmacokinetic analysis of the plasma concentration. Int. J. Pharm. 102, 141-149.
15. Pirson, P., Steiger, R., Trouet, A., 1982. The disposition of free and liposomally encapsulated antimalarial primaquine in mice. Biochem. Pharmacol. 31, 3501-3507.
16. Roland, A., Rohr, U., Kreuter, J., 1994. Transdermal delivery of the tetrapeptide histeal (Melanotropin (6-9)) and amino acids: their contribution to the elucidation of the existence of an 'Aqueous Pore' pathway. Int. J. Pharm. 107, 23-28.
17. Shah, J.C., 1996. Application of kinetic model to in vitro percutaneous permeation of drugs. Int. J. Pharm. 133, 179-189.
18. Winstanley, P.A., Breckenridge, A.M., 1987. Currently important antimalarial drugs. Ann. Trop. Med. Parasitol. 81, 619-627.